Temps réel Euronext Paris  -  17:35 04/07/2022
2.290 EUR   +0.66%
28/06TRANSGENE : accord de collaboration clinique avec MSD
28/06TRANSGENE : accord de collaboration clinique avec Merck
28/06Merck & Co. fournira le médicament Keytruda pour l'étude clinique de Transgene, BioInvent sur les tumeurs solides
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur TRANSGENE
04/07TOP STORIES ITALIA : piace agli analisti lo shopping in Francia di Exor
28/06Merck & Co. to Supply Keytruda Drug for Transgene, BioInvent's Clinical Study in Solid ..
28/06Transgene and Bioinvent Announces Clinical Trial Collaboration and Supply Agreement wit..
27/06TRANSGENE : Presentation
27/06Transgene SA and BioInvent International AB Announce Positive Progress for BT-001
15/06TRANSGENE : Virus Powered Immunotherapies against Solid Tumors
06/06Transgene SA Presented Additional Phase I Data with TG4050 at ASCO 2022
27/05Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials..
25/05Transgene SA Approves Board and Committee Changes
23/05Roche geht Partnerschaft mit US-Biotechfirma Kalivir Immunotherapeutics ein
22/04TRANSGENE : Presentation
31/03Transgene’S Board of Directors Proposes the Appointment of Dr. Alessandro Riva as ..
16/03TRANSCRIPT : Transgene SA, 2021 Earnings Call, Mar 16, 2022
16/03Transgene SA Reports Earnings Results for the Full Year Ended December 31, 2021
09/03Transgene to Present New Positive Preliminary Phase I Data on TG4050
08/03BioInvent and Transgene Announce Poster Presentation on BT-001, a Novel Antibody-encodi..
10/02Transgene Names Chief Business Officer
10/02Transgene SA Appoints Steven Bloom as Vice President and Chief Business Officer
20/01Transgene-BioInvent's Solid Tumor Drug Shows Potential Benefits in Preclinical Studies
20/01Bioinvent International AB & Transgene Joint JITC Publication Demonstrates the Potentia..
18/01Transgene and PersonGen Biotherapeutics Announce Collaboration to Evaluate New Combinat..
2021TRANSCRIPT : Transgene SA - Special Call
2021AstraZeneca Exercises Option for License to Oncolytic Virus Based on Transgene's Invir...
2021AstraZeneca Licenses Oncolytic Virus in Option Exercise Under Transgene Deal
2021Transgene Announces License Option Exercise by Astrazeneca for an Oncolytic Virus Gener..
2021TRANSCRIPT : Transgene SA - Special Call
2021Transgene and NEC Corporation Announce Positive Preliminary Data from Phase I Studies o..
2021Transgene and BioInvent Present Preclinical Data Highlighting the Robust Anti-Tumoral A..
2021BIOINVENT INTERNATIONAL : and Transgene to present preclinical data on BT-001 oncolytic vi..
2021Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2..
2021Certain Ordinary Shares of Transgene SA are subject to a Lock-Up Agreement Ending on 23..
2021TRANSCRIPT : Transgene SA, H1 2021 Earnings Call, Sep 22, 2021
2021TRANSGENE : Gastrointestinal Cancer Drug Study Confirms Potential of Cancer-Killing Virus
2021Transgene Presents Data from Phase I Clinical Trial Confirming the Potential of the Onc..
2021GLOBAL MARKETS LIVE : Valneva, Walt Disney, ViacomCBS, General Motors, Amazon...
2021GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla...
2021Transgene Participates in New Cancer Research Consortium
2021Transgene Announces Update on Phase I Clinical Trial of TG4050
2021GLOBAL MARKETS LIVE : Facebook, Toshiba, Fedex, Nike, Microsoft...
2021Transgene announces First Patient Enrolled in Expanded Phase II Clinical Trial of Tg400..
2021GLOBAL MARKETS LIVE : Netflix, Boeing, Tesla, Delta Air Lines, Blackstone Resources....
2021TRANSGENE : Raises $40.6 Million in Share Sale; Stock Falls 7%
2021EN DIRECTO DESDE LOS MERCADOS : EssilorLuxottica, Tesla, Zalando, Netflix, Stellantis, Exx..
2021Una vigilia de armas algo letárgica
2021EN DIRECTO DESDE LOS MERCADOS : Inditex, Banco Bilbao, Amazon, Renault, Autogrill, Clover ..
2021Transgene Strengthens Global IP Protection for its Novel Invir.IO™ Oncolytic Viruses En..
2021BioInvent, Transgene Win US FDA Nod For Phase 1/2a Study of Cancer Vaccine
2021BIOINVENT INTERNATIONAL : and Transgene receive IND approval from the U.S. FDA for BT-001,..
2021Bioinvent International AB and Transgene Receive IND Approval from the U.S. FDA for BT-..
2021GLOBAL MARKETS LIVE : Microsoft, Apple, Tesla...
2021TRANSGENE : April 27, 2021 - Transgene reports business update and end Q1 2021 financial p..
2021EN DIRECTO DESDE LOS MERCADOS : Alstom, Valneva, Credit Suisse, Givaudan, Just Eat, Air Fr..
2021TRANSGENE : April 12, 2021 - Transgene Announces Upcoming Investor Meetings
2021EN DIRECTO DESDE LOS MERCADOS : Michelin, Suez, Airbus, Dassault, Bénéteau, Cellectis, Cré..
2021TRANSGENE : April 9, 2021 - Transgene presents initial Phase I data of TG6002, highlightin..
2021Transgene Presents Initial Phase I Data of TG6002, Highlighting the Potential of the In..
2021TRANSGENE : April 7, 2021 - Availability of Preparatory Documents for the Combined General..
2021TRANSGENE : April 1, 2021 - Availability of Transgene's 2020 Universal Registration Docume..
2021Biden saca su chequera
2021OPINIONES DE LOS ANALISTAS DEL DÍA : LVMH, Michelin, Total, IAG, Tecan, Encavis, Royal Dut..
2021SGS : to Support Selecta Biosciences, AskBio's Phase One Trial for Genetic Disorder Treatm..
2021TRANSGENE BIOTEK : in Pact to Provide Oral, Nasal Formulations for COVID-19 Vaccine
2021TRANSCRIPT : Transgene SA, Q4 2020 Earnings Call, Mar 10, 2021
2021TRANSGENE : Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination W..
2021TRANSGENE : Significant Milestones Achieved on All Drug Candidates in 2020 and Financial V..
2021Transgene Sa Reports Earnings Results for the Full Year Ended December 31, 2020
2021Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination ..
2021Transgene SA Develops Individualized Immunotherapy Based on Multiple Advanced Genetic E..
2021TRANSGENE : March 10, 2021 - Transgene expands Phase II clinical trial of therapeutic vacc..
2021TRANSGENE : March 10, 2021 - Significant milestones achieved on all drug candidates in 202..
2021TRANSGENE : to Present Its Immuno-Oncology Expertise at Upcoming Scientific Conferences
2021TRANSGENE : March 2, 2021 - Transgene to Present its Immuno-Oncology Expertise at Upcoming..
2021Marzo ataca
2021TRANSGENE : BioInvent Enroll First Patient In Oncolytic Vaccinia Virus Trial
2021BIOINVENT INTERNATIONAL : and Transgene has enrolled first patient in Phase I/IIa trial of..
1  2  3  4  5  6Suiv.
Prochain événement sur TRANSGENE